Dr Scott Gottlieb says Covid booster may still be needed in fall
However, Gottlieb, who sits on the board of directors of the vaccine manufacturer Pfizer, said an extra dose may still be needed later this year to boost immunity.
“I think you might feel safe in the summer,” the former Food and Drug Administration commissioner said on “Screaming box.” “The combination of the protective immunity that people get from vaccination – although it decreases over time – combined with the fact that the prevalence is very low, I think people could feel reasonably secure throughout the entire period. ‘summer.”
“It would be nice if it turned out that it would be a year before someone needed a booster,” Dr Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA, said last month. “But we still don’t know,” Marks added. “It could be more, it could be a little less but… it’s just something that we will have to figure out as we go along.”
Gottlieb, who led the FDA from 2017 to 2019 in the Trump administration, said more clarity on the timeline could arrive in the coming months.
“I think as the fall approaches, we will have to consider giving, especially to the vulnerable population, boosters,” said Gottlieb, predicting that these discussions will be more focused after July 4. This is when the president Joe biden set a goal of have 70% of American adults at least partially vaccinated against the Covid.
Currently, 63.5% of the country’s adult population have received at least one dose of the Covid vaccine, according to data compiled by the Centers for Disease Control and Prevention. About 53% of U.S. adults are fully immunized, according to CDC data.
The pace of vaccinations against Covid slowed down in recent weeks, and Gottlieb said he expects this to persist into July and August. At this point, Gottlieb said Americans who haven’t been vaccinated might decide to get the shot before they go back to work or have their kids go back to school.
Disclosure: Scott Gottlieb is a CNBC contributor and serves on the boards of directors of Pfizer, genetic testing startup Tempus, health technology company Aetion, and biotech company Illumina. He is also co-chair of Norwegian Cruise Line Holdings‘and Royal Caribbean‘s “Healthy sail panel.”